ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

RFA/PA/Drug Group Announcement Limited

May 6, 1988

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

February 24, 2006

Federal AIDS Funds Tp $2 Bil.; Term Proposed For NIH Director

October 19, 1990

Senate Resolution Urges CMS To Reopen Coverage Policy on ESAs In Oncology.

September 7, 2007

Facility Needs Panel Recommends $4.5-3 billion, Seven Year Program To Be Run By NIGMS Or DRR

March 4, 1988

DCBDC board Okays RFA concept On AIDS Lymphoma

March 26, 1993